Team:Paris Bettencourt/Achievements

From 2012.igem.org

(Difference between revisions)
(Achievements of all the different modules)
Line 11: Line 11:
<td>
<td>
'''Achievements :'''
'''Achievements :'''
 +
 +
'''Semantic containment'''
* Construction and characterization of 2 biobricks :
* Construction and characterization of 2 biobricks :
** [http://partsregistry.org/Part:BBa_K914000 K914000] : P<sub>Lac</sub>-supD-T : tRNA amber suppressor
** [http://partsregistry.org/Part:BBa_K914000 K914000] : P<sub>Lac</sub>-supD-T : tRNA amber suppressor
Line 17: Line 19:
The first part (supD) is well characterized and works well. For the second parts, it turns out that this mutation is quite leaky, although it works in lab conditions, one mutation is not enough if we want to release such parts in nature. Other reasons emphasize this observation, notably the weakness of being at one mutation to recover the protein functionality.
The first part (supD) is well characterized and works well. For the second parts, it turns out that this mutation is quite leaky, although it works in lab conditions, one mutation is not enough if we want to release such parts in nature. Other reasons emphasize this observation, notably the weakness of being at one mutation to recover the protein functionality.
* Creation of a new category in the part registry : [http://partsregistry.org/Biosafety Semantic containment]. The aim of this category is to let people improving each part by adding for instance other amber mutations to existing part to increase the containment.
* Creation of a new category in the part registry : [http://partsregistry.org/Biosafety Semantic containment]. The aim of this category is to let people improving each part by adding for instance other amber mutations to existing part to increase the containment.
-
</td>
 
-
</tr>
 
-
</table>
 
-
 
+
'''Resctriction enzyme system'''
-
<table id="tableboxed">
+
-
<tr>
+
-
<td>
+
-
'''Achievements :'''
+
* Construction of 4 biobricks [https://2012.igem.org/Team:Paris_Bettencourt/Restriction_Enzyme#Design &#091;Read more&#093;]:
* Construction of 4 biobricks [https://2012.igem.org/Team:Paris_Bettencourt/Restriction_Enzyme#Design &#091;Read more&#093;]:
** [http://partsregistry.org/Part:BBa_K914003 K914003]: L-rhamnose-inducible promoter
** [http://partsregistry.org/Part:BBa_K914003 K914003]: L-rhamnose-inducible promoter
Line 37: Line 32:
** [http://partsregistry.org/Part:BBa_K175027 K175027]: I-SceI restriction site
** [http://partsregistry.org/Part:BBa_K175027 K175027]: I-SceI restriction site
* Currently we are in process of [https://2012.igem.org/Team:Paris_Bettencourt/Restriction_Enzyme#Design L-rhamnose-inducible promoter (pRha)] caracterisation. [https://2012.igem.org/Team:Paris_Bettencourt/Restriction_Enzyme#Characterisation_of_pRha &#091;Read more&#093;]
* Currently we are in process of [https://2012.igem.org/Team:Paris_Bettencourt/Restriction_Enzyme#Design L-rhamnose-inducible promoter (pRha)] caracterisation. [https://2012.igem.org/Team:Paris_Bettencourt/Restriction_Enzyme#Characterisation_of_pRha &#091;Read more&#093;]
-
</tr>
 
-
</table>
 
 +
'''Suicide system'''
-
<table id="tableboxed">
 
-
<tr>
 
-
<td>
 
-
'''Achievements :'''
 
We showed that Colicin E2 cells induce cell death in sensitive populations, and that these sensitive populations can be protected by providing them with our engineered immunity protein.  
We showed that Colicin E2 cells induce cell death in sensitive populations, and that these sensitive populations can be protected by providing them with our engineered immunity protein.  
* Construction of 2 biobricks :
* Construction of 2 biobricks :
Line 51: Line 41:
Part K914001 is well characterized and provides immunity to sensitive cells against the Colicin E2 activity protein, but is leaky. Part K914002 is promoterless and allows users to easily plug in the appropriate promoter for their desired purpose.  
Part K914001 is well characterized and provides immunity to sensitive cells against the Colicin E2 activity protein, but is leaky. Part K914002 is promoterless and allows users to easily plug in the appropriate promoter for their desired purpose.  
* Creation of a new category in the part registry : [http://partsregistry.org/Biosafety XNase]. The aim of this category is to provide users with DNase/RNase parts that can be used for improved kill switches featuring the degradation of genomic material.
* Creation of a new category in the part registry : [http://partsregistry.org/Biosafety XNase]. The aim of this category is to provide users with DNase/RNase parts that can be used for improved kill switches featuring the degradation of genomic material.
-
</tr>
 
-
</table>
 
-
 
-
 
-
 
-
<table id="tableboxed">
 
-
<tr>
 
-
<td>
 
-
 
-
'''Achievements'''
 
 +
'''MAGE'''
*Proof of concept by introducing a stop codon in the middle of the lacZ gene using multiplex automated genome engineering (MAGE)
*Proof of concept by introducing a stop codon in the middle of the lacZ gene using multiplex automated genome engineering (MAGE)
-
</td>
+
'''Synthetic Import Domain'''
-
</tr>
+
-
</table>
+
-
 
+
-
 
+
-
 
+
-
 
+
-
<table id="tableboxed">
+
-
<tr>
+
-
<td>
+
-
 
+
-
'''Achievements'''
+
-
 
+
*Construction of colicin-like toxin by fusing Colicin E2 based "Synthetic Import Domain" with RNAse domain of colicin D
*Construction of colicin-like toxin by fusing Colicin E2 based "Synthetic Import Domain" with RNAse domain of colicin D
*Constructon of FseI, I-SceI, LuxR active fragment, LacZ alpha fragment, PyrF and T7 RNA polymerase fused to the two types of "Synthetic Import Domains" from Colicin E2 and Colicin D
*Constructon of FseI, I-SceI, LuxR active fragment, LacZ alpha fragment, PyrF and T7 RNA polymerase fused to the two types of "Synthetic Import Domains" from Colicin E2 and Colicin D

Revision as of 01:15, 27 September 2012


iGEM Paris Bettencourt 2012


Achievements

Achievements of all the different modules

Achievements :

Semantic containment

  • Construction and characterization of 2 biobricks :
    • K914000 : PLac-supD-T : tRNA amber suppressor
    • K914009 : P1003* Ser133->Amber Codon : kanamycin gene resistance with 1 amber mutation

The first part (supD) is well characterized and works well. For the second parts, it turns out that this mutation is quite leaky, although it works in lab conditions, one mutation is not enough if we want to release such parts in nature. Other reasons emphasize this observation, notably the weakness of being at one mutation to recover the protein functionality.

  • Creation of a new category in the part registry : Semantic containment. The aim of this category is to let people improving each part by adding for instance other amber mutations to existing part to increase the containment.

Resctriction enzyme system

  • Construction of 4 biobricks [Read more]:
    • K914003: L-rhamnose-inducible promoter
    • K914005: Meganuclease I-SceI controlled by pLac
    • K914007: Meganuclease I-SceI controlled by pBad
    • K914008: Meganuclease I-SceI controlled by pRha
  • Demonstration that all 3 generators (K914005, K914007, K914008) work and express I-SceI meganuclease in cells. [Read more]

Suicide system

We showed that Colicin E2 cells induce cell death in sensitive populations, and that these sensitive populations can be protected by providing them with our engineered immunity protein.

  • Construction of 2 biobricks :
    • K914001 : pLac-repressilator RBS-Colicin E2 immunity protein
    • K914002 :repressilator RBS-Colicin E2 immunity protein

Part K914001 is well characterized and provides immunity to sensitive cells against the Colicin E2 activity protein, but is leaky. Part K914002 is promoterless and allows users to easily plug in the appropriate promoter for their desired purpose.

  • Creation of a new category in the part registry : XNase. The aim of this category is to provide users with DNase/RNase parts that can be used for improved kill switches featuring the degradation of genomic material.

MAGE

  • Proof of concept by introducing a stop codon in the middle of the lacZ gene using multiplex automated genome engineering (MAGE)

Synthetic Import Domain

  • Construction of colicin-like toxin by fusing Colicin E2 based "Synthetic Import Domain" with RNAse domain of colicin D
  • Constructon of FseI, I-SceI, LuxR active fragment, LacZ alpha fragment, PyrF and T7 RNA polymerase fused to the two types of "Synthetic Import Domains" from Colicin E2 and Colicin D
  • Proof of concept with LacZ alpha fragment fused to "Synthetic Import Domain" from Colicin D


Copyright (c) 2012 igem.org. All rights reserved. Design by FCT.